Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 2, 2009, Pages 160.e1-160.e9

  Mandelbrot, Laurent ^a,b   Jasseron, Carine ^b,c,e   Ekoukou, Dieudonné ^l   Batallan, Agnès ^f   Bongain, André ^m   Pannier, Emmanuelle ^g   Blanche, Stéphane ^h,j   Tubiana, Roland ^k   Rouzioux, Christine ^i,j   Warszawski, Josiane ^b,c,d,e  

^a HÔPITAL LOUIS MOURIER   (France)

^b INSERM   (France)

^c BICÊTRE HOSPITAL   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^f BICHAT HOSPITAL   (France)

^g AP HP Hôpital Cochin ^*  (France)

^h Unité d'Immunologie Hématologie   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l DELAFONTAINE HOSPITAL   (France)

^m CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

more..

Author keywords

amniocentesis; antiretroviral therapy; human immunodeficiency virus; mother to child transmission; pregnancy; prenatal diagnosis

Indexed keywords

RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; AMNIOCENTESIS; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MONOTHERAPY; PERINATAL CARE; PRIORITY JOURNAL;

EID: 58749107130     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.08.049     Document Type: Article

References (26)

1. Mandelbrot L., Landeau-Mascaro A., Rekacewicz C., et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 285 (2001) 2083-2093
2. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40 (2005) 458-465
3. Dorenbaum A., Cunningham C.K., Gelber R.D., et al. Addition of two-dose intrapartum/newborn nevirapine to standard antiretroviral therapy to reduce perinatal HIV-1 transmission: PACTG 316. JAMA 288 (2002) 189-198
4. Coll O., Suy A., Hernandez S., et al. Prenatal diagnosis in human immunodeficiency virus-infected women: a new screening program for chromosomal anomalies. Am J Obstet Gynecol 194 (2006) 192-198
5. Somigliana E., Bucceri A.M., Tibaldi C., et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series. Am J Obstet Gynecol 193 (2005) 437-442
6. Tabor A., Bang J., and Norgaard-Pedersen B. Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. BJOG 94 (1987) 528-553
7. Mujezinovic F., and Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 110 (2007) 687-694
8. Minola E., Maccabruni A., Pacati I., and Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C. Hepatology 33 (2001) 1341-1342
9. Mandelbrot L., Mayaux M.J., Bongain A., et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 175 (1996) 661-667
10. Mandelbrot L., Brossard Y., Aubin J.T., et al. Testing for in utero human immunodeficiency virus infection with fetal blood sampling. Am J Obstet Gynecol 175 (1996) 489-493
11. Warszawski J., Tubiana R., Le Chenadec J., et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 22 (2008) 289-299
12. Mayaux M.J., Teglas J.P., Mandelbrot L., et al. Acceptability and impact of zidovudine prevention on mother-to-child HIV-1 transmission in France. J Pediatr 131 (1997) 857-862
13. In: Yeni P. (Ed). Prise en charge médicale des personnes infectées par le VIH (2006), Flammarion, Paris (France)
14. Delfraissy J.F., and pour les groupes d'experts cliniciens et virologues. Stratégies d'utilisation des antirétroviraux dans l'infection par le VIH (1999), Flammarion, Paris (France) 143-160
15. Centers for Disease Control and Prevention. Updated US Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Morbid Mortal Wkly Rep 54 (2005) RR-9
16. Shapiro D.E., Sperling R.S., Mandelbrot L., Britto P., and Cunningham B.E. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. PACTG 076 Study Group. Obstet Gynecol 94 (1999) 897-908
17. Tess B.H., Rodrigues L.C., Newell M.L., Dunn D.T., Lago T., and Sao Paulo Collaborative Study for Vertical Transmission of HIV-1 5. Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. AIDS 12 (1998) 513-520
18. Rouzioux C., Costagliola D., Burgard M., et al. Estimated timing of mother-to-child human immunodeficiency virus type I transmission by use of a Markov model. Am J Epidemiol 142 (1995) 1330-1337
19. Maiques V., Garcia-Tejedor A., Perales A., Cordoba J., and Esteban R.J. HIV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women?. Eur J Obstet Gynecol Reprod Biol 108 (2003) 137-141
20. Blondel B., Supernant K., du Mazaubrun C., and Bréart G. INSERM U. 149. Enquête Nationale Périnatale-2003. Situation en 2003 et évolution depuis 1998. Paris (2005). www.sante.gouv.fr/htm/dossiers/perinat03/sommaire.htm Accessed May 7, 2008.
21. Haute Autorité de Santé. Evaluation des stratégies de dépistage de la trisomie 21 (June 2007). www.has-sante.fr/portail/display.jsp?id=c_540873 Accessed May 7, 2008
22. ACOG Committee on Practice Bulletins. ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 109 (2007) 217-227
23. Yudin M.H., Prosen T.L., and Landers D.V. Multiple-marker screening in human immunodeficiency virus-positive pregnant women: screen positivity rates with the triple and quad screens. Am J Obstet Gynecol 189 (2003) 973-976
24. Khoshnood B., De Vigan C., Vodovar V., Goujard J., and Goffinet F. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. BJOG 111 (2004) 485-490
25. Giorlandino C., Gambuzza G., D'Alessio P., Santoro M.L., Gentili P., and Vizzone A. Blood contamination of amniotic fluid after amniocentesis in relation to placental location. Prenat Diagn 16 (1996) 180-182
26. Katiyar R., Kriplani A., Agarwal N., Bhatla N., and Kabra M. Detection of fetomaternal hemorrhage following chorionic villus sampling by Kleihauer Betke test and rise in maternal serum alpha fetoprotein. Prenat Diagn 27 (2007) 139-142